Literature DB >> 15024708

Delayed remodeling in the early period of fracture healing in spontaneously diabetic BB/OK rats depending on the diabetic metabolic state.

N Follak1, L Klöting, E Wolf, H Merk.   

Abstract

Several clinical series, analyzing fracture healing in patients with insulin-dependent type 1 diabetes (IDDM) demonstrated significant incidence of delayed union, non-union, and pseudarthrosis. The purpose of this study was to examine the detailed histomorphometry and histology of bone formation and remodeling during fracture healing depending on the diabetic metabolic state in spontaneously diabetic BB/O(ttawa)K(arlsburg) rats, a rat strain that represents a close homology to IDDM in man. A standardized fracture model was chosen and based on blood-glucose values at the time of surgery (mg%), postoperative blood-glucose course (mg%) and postoperative insulin requirements (IU/kg), 100 spontaneously diabetic BB/OK rats were divided into groups with well-compensated (n=50, 167+/-77 mg%; 244+/-68 mg%; 1.8+/-1.9 IU/kg) or poorly compensated (n=50, 380+/-89 mg%; 415+/-80 mg%; 6.0+/-1.0 IU/kg) metabolic state. Fifty LEW.1A rats served as the normoglycemic controls (97+/-15 mg%). Ten animals from each group were killed 1, 2, 3, 4 and 6 weeks after fracture and specimens were processed undecalcified for quantitative histomorphometry and for qualitative light microscopy. In terms of bone histomorphometry, within the first four weeks after fracture, severe mineralization disorders occurred exclusively in the rats with poorly compensated diabetic metabolic states with a significantly decrease of all fluorochrome-based parameters of mineralization, apposition, formation and timing of mineralization in comparison to the spontaneously diabetic rats with well-compensated metabolic states and to the control rats. This was confirmed histologically. Early fracture healing in the spontaneously diabetic BB/OK rats is delayed exclusively in poorly compensated diabetic metabolic states, and 6 weeks after fracture, histomorphometrically significant deficits in the measured and dynamically calculated parameters remain. This study suggests that strictly controlled insulin treatment resulting in well-compensated diabetic metabolic states will ameliorate the impaired early mineralization and cell differentiation disorders of IDDM fracture healing.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15024708     DOI: 10.14670/HH-19.473

Source DB:  PubMed          Journal:  Histol Histopathol        ISSN: 0213-3911            Impact factor:   2.303


  17 in total

Review 1.  Diabetes pharmacotherapy and effects on the musculoskeletal system.

Authors:  Evangelia Kalaitzoglou; John L Fowlkes; Iuliana Popescu; Kathryn M Thrailkill
Journal:  Diabetes Metab Res Rev       Date:  2018-12-20       Impact factor: 4.876

Review 2.  A critical review of diabetes, glycemic control, and dental implant therapy.

Authors:  Thomas W Oates; Guy Huynh-Ba; Adriana Vargas; Peggy Alexander; Jocelyne Feine
Journal:  Clin Oral Implants Res       Date:  2011-11-24       Impact factor: 5.977

Review 3.  Is insulin an anabolic agent in bone? Dissecting the diabetic bone for clues.

Authors:  Kathryn M Thrailkill; Charles K Lumpkin; R Clay Bunn; Stephen F Kemp; John L Fowlkes
Journal:  Am J Physiol Endocrinol Metab       Date:  2005-11       Impact factor: 4.310

4.  Diminished bone formation during diabetic fracture healing is related to the premature resorption of cartilage associated with increased osteoclast activity.

Authors:  Rayyan A Kayal; Dimitris Tsatsas; Megan A Bauer; Brian Allen; Maisa O Al-Sebaei; Sanjeev Kakar; Cataldo W Leone; Elise F Morgan; Louis C Gerstenfeld; Thomas A Einhorn; Dana T Graves
Journal:  J Bone Miner Res       Date:  2007-04       Impact factor: 6.741

5.  Amelioration of type I diabetes-induced osteoporosis by parathyroid hormone is associated with improved osteoblast survival.

Authors:  Katherine J Motyl; Laurie K McCauley; Laura R McCabe
Journal:  J Cell Physiol       Date:  2012-04       Impact factor: 6.384

6.  Osteo-promoting effects of insulin-like growth factor I (IGF-I) in a mouse model of type 1 diabetes.

Authors:  John L Fowlkes; Jeffry S Nyman; R Clay Bunn; Chanhee Jo; Elizabeth C Wahl; Lichu Liu; Gael E Cockrell; Lindsey M Morris; Charles K Lumpkin; Kathryn M Thrailkill
Journal:  Bone       Date:  2013-07-23       Impact factor: 4.398

7.  Osteogenic progenitors in bone marrow aspirates have clinical potential for tibial non-unions healing in diabetic patients.

Authors:  Charles Henri Flouzat-Lachaniette; Clemence Heyberger; Charlie Bouthors; François Roubineau; Nathalie Chevallier; Helene Rouard; Philippe Hernigou
Journal:  Int Orthop       Date:  2015-11-17       Impact factor: 3.075

8.  Contributions of the Insulin/Insulin-Like Growth Factor-1 Axis to Diabetic Osteopathy.

Authors:  John L Fowlkes; Clay Bunn R; Kathryn M Thrailkill
Journal:  J Diabetes Metab       Date:  2011-11-25

9.  Glycemic control and implant stabilization in type 2 diabetes mellitus.

Authors:  T W Oates; S Dowell; M Robinson; C A McMahan
Journal:  J Dent Res       Date:  2009-04       Impact factor: 6.116

10.  Imbalance of RANK, RANKL and OPG expression during tibial fracture repair in diabetic rats.

Authors:  Fernanda Penna Lima Guedes de Amorim; Sócrates Souza Ornelas; Sandoval Felicíssimo Diniz; Aline Carvalho Batista; Tarcília Aparecida da Silva
Journal:  J Mol Histol       Date:  2008-07-01       Impact factor: 2.611

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.